Retraction notices

Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA

Type

Retraction

Notice date

10/20/2024 0:00

Journal

Annals of Translational Medicine

Publisher

AME Publishing Company

Notice DOI

10.21037/atm-2022-75

Original paper DOI

10.21037/atm-20-5586

Reasons

• Results Not Reproducible
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Annals of Translational Medicine